Skip to main content
. 2022 Apr 28;3(2):101360. doi: 10.1016/j.xpro.2022.101360

Figure 2.

Figure 2

LIVE/DEAD Assay of hiPSC (253G4)-derived cardiomyocytes (hiPSC-CMs) treated with or without 6 μM orlistat for 72 h

Orlistat treatment does not affect the viability of hiPSC- CMs. Scale bars: 200 μm.